Differences in histological features may account for an additional part of the reported variations in the primary BC lesion activity, with ductal and HER-2 positive tumors showing a trend for a greater uptake than lobular and the HER-2 negative counterpart. This evidence concerns the gene ERBB2 and breast cancer.